Dietary practices in pyridoxine non-responsive homocystinuria: A European survey

Molecular Genetics and Metabolism

Volumn 110, Issue 4, 2013, Pages 454-459

  Adam, S ^a   Almeida, M F ^b   Carbasius Weber, E ^c   Champion, H ^d   Chan, H ^e   Daly, A ^f   Dixon, M ^g   Dokoupil, K ^h   Egli, D ⁱ   Evans, S ^f   Eyskens, F ^j   Faria, A ^k   Ferguson, C ^l   Hallam, P ^m   Heddrich Ellerbrok, M ⁿ   Jacobs, J ^o   Jankowski, C ^p   Lachmann, R ^e   Lilje, R ^q   Link, R ^r   Lowry, S ^s   Luyten, K ^j   MacDonald, A ^f   Maritz, C ^e   Martins, E ^t   Meyer, U ^u   Muller E ^v   Murphy, E ^e   Robertson, L V ^w   Rocha, J C ^b   Saruggia, I ^x   Schick, P ^y   Stafford, J ^g   Stoelen, L ^q   Terry, A ^y   Thom, R ^z   van den Hurk, T ^c   van Rijn, M ^aa   van Teefelen Heithoff, A ^ab   Webster, D ^p   White, F J ^ac   Wildgoose, J ^ad   Zweers, H ^ae   more..

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UP   (Portugal)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e Charles Dent Metabolic Unit   (United Kingdom)

^f BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j Centre of IMD   (Belgium)

^k CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^l NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^m EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^o UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^p UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^q OSLO UNIVERSITY HOSPITAL   (Norway)

^r Chair SSIEM DG   (Germany)

^s SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^t Maria Pia Hospital Central Hospital of Porto   (Portugal)

^u HANNOVER MEDICAL SCHOOL   (Germany)

^v Centre of Child and Adolescent Medicine   (Germany)

^w UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^x Reference Centre for Hereditary Metabolic Diseases PR Chabrol   (France)

^y ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^z ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^aa UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ab UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^ac MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^ad BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^ae RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Betaine; Homocysteine; Homocystinuria; Methionine; Protein restricted diet

Indexed keywords

BETAINE; HOMOCYSTEINE; HOMOCYSTINE; METHIONINE; PROTEIN;

ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; BELGIUM; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET THERAPY; EUROPE; FRANCE; GERMANY; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MULTICENTER STUDY (TOPIC); NETHERLANDS; NEWBORN SCREENING; NORWAY; PORTUGAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN RESTRICTION; PYRIDOXINE NON RESPONSIVE HOMOCYSTINURIA; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCHOOL CHILD; SWITZERLAND; TREATMENT OUTCOME; UNITED KINGDOM;

BETAINE; HOMOCYSTEINE; HOMOCYSTINURIA; METHIONINE; PROTEIN RESTRICTED DIET;

ADOLESCENT; ADULT; BETAINE; CHILD; CHILD, PRESCHOOL; DIET, PROTEIN-RESTRICTED; EUROPE; FEMALE; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; INFANT; MALE; METHIONINE; PYRIDOXINE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84897094877     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.10.003     Document Type: Article

References (32)

1. Skovby F., Gaustadnes M., Mudd S.H. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol. Genet. Metab. 2010, 99(1):1-3.
2. Maclean K.N., Jiang H., Greiner L.S., Allen R.H., Stabler S.P. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. Mol. Genet. Metab. 2012, 105(3):395-403.
3. Yap S., Rushe H., Howard P.M., Naughten E.R. The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency. J. Inherit. Metab. Dis. 2001, 24(4):437-447.
4. Yap S., Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J. Inherit. Metab. Dis. 1998, 21(7):738-747.
5. Mulvihill A., Yap S., O'Keefe M., Howard P.M., Naughten E.R. Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population. J. AAPOS 2001, 5(5):311-315.
6. Yap S. Classical homocystinuria: vascular risk and its prevention. J. Inherit. Metab. Dis. 2003, 26(2-3):259-265.
7. Kaeser A.C., Rodnight R., Ellis B.A. Psychiatric and biochemical aspects of a case of homocystinuria. J. Neurol. Neurosurg. Psychiatry 1969, 32(2):88-93.
8. Garland J., Prasad A., Vardy C., Prasad C. Homocystinuria: challenges in diagnosis and management. Paediatr. Child Health 1999, 4(8):557-562.
9. Abbott M.H., Folstein S.E., Abbey H., Pyeritz R.E. Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am. J. Med. Genet. 1987, 26(4):959-969.
10. Ryan M.M., Sidhu R.K., Alexander J., Megerian J.T. Homocystinuria presenting as psychosis in an adolescent. J. Child Neurol. 2002, 17(11):859-860.
11. Naughten E.R., Yap S., Mayne P.D. Newborn screening for homocystinuria: Irish and world experience. Eur. J. Pediatr. 1998, 157(Suppl. 2):S84-S87.
12. Refsum H., Grindflek A.W., Ueland P.M., Fredriksen A., Meyer K., Ulvik A., Guttormsen A.B., Iversen O.E., Schneede J., Kase B.F. Screening for serum total homocysteine in newborn children. Clin. Chem. 2004, 50(10):1769-1784.
13. Janosík M., Sokolová J., Janosíková B., Krijt J., Klatovská V., Kozich V. Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J. Pediatr. 2009, 154(3):431-437.
14. Walter J.H., Jahnke N., Remmington T. Newborn screening for homocystinuria. Cochrane Database Syst. Rev. 2011, 10(8):CD008840.
15. Cruysberg J.R., Boers G.H., Trijbels J.M., Deutman A.F. Delay in diagnosis of homocystinuria: retrospective study of consecutive patients. BMJ 1996, 313(7064):1037-1040.
16. Walter J.H., Wraith J.E., White F.J., Bridge C., Till J. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30years. Eur. J. Pediatr. 1998, 157(Suppl. 2):S71-S76.
17. Komrower G.M. Dietary treatment of homocystinuria. Am. J. Dis. Child. 1967, 113(1):98-100.
18. Olthof M.R., Verhoef P. Effects of betaine intake on plasma homocysteine concentrations and consequences for health. Curr. Drug Metab. 2005, 6(1):15-22.
19. Sakamoto A., Sakura N. Limited effectiveness of betaine therapy for cystathionine beta synthase deficiency. Pediatr. Int. 2003, 45(3):333-338.
20. Wilcken D.E., Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J. Inherit. Metab. Dis. 1997, 20(2):295-300.
21. Andria G., Fowler B., Sebastio G. Disorders of sulfur amino acid metabolism. Inborn Metabolic Diseases 2012, 311-320. Springer-Verlag, Berlin. J.M. Saudubray, G. van den Berghe, J.H. Walter (Eds.).
22. Schiff M., Blom H. Treatment of inherited homocystinurias. Neuropediatrics 2012, 43:295-304.
23. Matthews A., Johnson T.N., Rostami-Hodjegan A., Chakrapani A., Wraith J.E., Moat S.J., Bonham J.R., Tucker G.T. An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. Br. J. Clin. Pharmacol. 2002, 54(2):140-146.
24. Singh R.H., Kruger W.D., Wang L., Pasquali M., Elsas L.J. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genet. Med. 2004, 6(2):90-95.
25. Betaine Summary of product characteristics (Accessed August, 2013). http://www.ema.europa.eu.
26. BNF for Children 2011-2012 2011, BMJ Group, Pharmaceutical Press, RCPCH Publications Ltd., London.
27. Devlin A.M., Hajipour L., Gholkar A., Fernandes H., Ramesh V., Morris A.A. Cerebral edema associated with betaine treatment in classical homocystinuria. J. Pediatr. 2004, 144(4):545-548.
28. Yaghmai R., Kashani H., Geraghty M.T., Okoh J., Pomper M., Tangerman A., Wagner C., Stabler S.P., Allen R.H., Mudd S.H., Braverman N. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am. J. Med. Genet. 2002, 108(1):57-63.
29. MacDonald A., White F. Dietary Management of Amino Acid Disorders. Clinical Paediatric Dietetics 2013, Blackwell Publishing, Oxford, (in press). V. Shaw (Ed.).
30. Lee P.J., Briddon A. A rationale for cystine supplementation in severe homocystinuria. J. Inherit. Metab. Dis. 2007, 30(1):35-38.
31. Moat S.J., Bonham J.R., Tanner M.S., Allen J.C., Powers H.J. Recommended approaches for the laboratory measurement of homocysteine in the diagnosis and monitoring of patients with hyperhomocysteinaemia. Ann. Clin. Biochem. 1999, 36(Pt 3):372-379.
32. Bilginsoy C., Waitzman N., Leonard C.O., Ernst S.L. Living with phenylketonuria: perspectives of patients and their families. J. Inherit. Metab. Dis. 2005, 28(5):639-649.